Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance

Amgen, Inc.
ZIM Integrated Shipping Services Ltd

Price performance

Price movement over the last 24 hours

Key statistics

Amgen, Inc. vs ZIM Integrated Shipping Services Ltd — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while ZIM Integrated Shipping Services Ltd trades at $23.83 (market cap $2.89B). The key difference: Amgen, Inc. is far larger — about 67.9× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays the higher dividend (7.88%). Which is the better fit depends on your goals.

AMGNZIM
Market Cap
$196.12B$2.89B
Sector
HealthIndustrials
52-Week High
$388.16$29.27
52-Week Low
$271.18$12.44
Enterprise Value
$241.41B$6.74B
Dividend Yield
2.77%7.88%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amgen, Inc.

AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.

The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.

ZIM Integrated Shipping Services Ltd

ZIM trades at $23.97, down 0.7% on the day, with a bearish technical signal from moving averages. The company reported a Q1 2026 net loss of $86 million, missing EPS expectations, though revenue pressure from lower freight rates may be offset by recent supply chain disruptions. Valuation metrics show a low P/S of 0.46 and P/B of 0.76, suggesting potential undervaluation relative to assets. Key developments include a pending merger with Hapag-Lloyd facing regulatory hurdles and a rival $4.5 billion takeover bid from Haim Sakal.

The outlook for ZIM is clouded by operational challenges and merger uncertainty, but current asset-based valuations provide a floor near $29–$30 per share. Investment opportunity exists if merger approvals proceed or freight rates rebound from Hormuz blockade effects. Primary risks include regulatory rejection of deals, sustained earnings pressure, and high debt-to-asset ratio of 0.71. Analyst consensus is split evenly between Hold and Sell with a $16.75 price target, indicating cautious sentiment amid speculative M&A dynamics.

Returns comparison

Trailing returns across standard periods

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About ZIM Integrated Shipping Services Ltd

ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.

Read more on ZIM